BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 2302668)

  • 1. The prognostic significance of tumor ploidy and pathology in adenocarcinoma of the esophagogastric junction.
    Schneeberger AL; Finley RJ; Troster M; Lohmann R; Keeney M; Inculet RI
    Cancer; 1990 Mar; 65(5):1206-10. PubMed ID: 2302668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of DNA ploidy and c-erbB-2 oncoprotein overexpression in adenocarcinoma of Barrett's esophagus.
    Nakamura T; Nekarda H; Hoelscher AH; Bollschweiler E; Harbeck N; Becker K; Siewert JR; Harbec N [corrected to Harbeck N]
    Cancer; 1994 Apr; 73(7):1785-94. PubMed ID: 7907940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymph node metastases of adenocarcinoma of the esophagus and esophagogastric junction.
    Zhang X; Watson DI; Jamieson GG
    Chin Med J (Engl); 2007 Dec; 120(24):2268-70. PubMed ID: 18167216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of DNA ploidy in patients with stage II and stage III colon carcinoma: a prospective flow cytometric study.
    Lanza G; Gafà R; Santini A; Maestri I; Dubini A; Gilli G; Cavazzini L
    Cancer; 1998 Jan; 82(1):49-59. PubMed ID: 9428479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinicopathological features and prognostic factors of adenocarcinoma of the esophagogastric junction according to Siewert classification: experiences at a single institution in Japan.
    Hosokawa Y; Kinoshita T; Konishi M; Takahashi S; Gotohda N; Kato Y; Daiko H; Nishimura M; Katsumata K; Sugiyama Y; Kinoshita T
    Ann Surg Oncol; 2012 Feb; 19(2):677-83. PubMed ID: 21822549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prognostic significance of DNA ploidy in adenocarcinomas of the esophagogastric junction.
    Sarbia M; Molsberger G; Willers R; Horstmann O; Schroders C; Porschen R; Gabbert H E
    J Cancer Res Clin Oncol; 1996; 122(3):186-88. PubMed ID: 8601569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extranodal metastasis is a powerful prognostic factor in patients with adenocarcinoma of the esophagogastric junction.
    Zhang HD; Tang P; Duan XF; Chen CG; Ma Z; Gao YY; Zhang H; Yu ZT
    J Surg Oncol; 2013 Dec; 108(8):542-9. PubMed ID: 24018956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenocarcinomas of the esophagogastric junction: experiences at a single institution in China.
    Zhang H; Wang W; Cheng Y; Song Y; Zhu K; Dang C
    World J Surg Oncol; 2013 Jul; 11():155. PubMed ID: 23849250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significance of the depth of tumor invasion and lymph node metastasis in superficially invasive (T1) esophageal adenocarcinoma.
    Liu L; Hofstetter WL; Rashid A; Swisher SG; Correa AM; Ajani JA; Hamilton SR; Wu TT
    Am J Surg Pathol; 2005 Aug; 29(8):1079-85. PubMed ID: 16006804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor stage after neoadjuvant chemotherapy determines survival after surgery for adenocarcinoma of the esophagus and esophagogastric junction.
    Davies AR; Gossage JA; Zylstra J; Mattsson F; Lagergren J; Maisey N; Smyth EC; Cunningham D; Allum WH; Mason RC
    J Clin Oncol; 2014 Sep; 32(27):2983-90. PubMed ID: 25071104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Personalizing risk stratification by addition of PAK1 expression to TNM staging: improving the accuracy of clinical decision for gastroesophageal junction adenocarcinoma.
    Li Z; Zou X; Xie L; Chen H; Chen Y; Yeung SC; Zhang H
    Int J Cancer; 2015 Apr; 136(7):1636-45. PubMed ID: 25159681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of epidermal growth factor receptor in esophageal and esophagogastric junction adenocarcinomas: association with poor outcome.
    Wang KL; Wu TT; Choi IS; Wang H; Resetkova E; Correa AM; Hofstetter WL; Swisher SG; Ajani JA; Rashid A; Albarracin CT
    Cancer; 2007 Feb; 109(4):658-67. PubMed ID: 17211865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of DNA ploidy in adenocarcinoma of the pancreas. A flow cytometric study of paraffin-embedded specimens.
    Porschen R; Remy U; Bevers G; Schauseil S; Hengels KJ; Borchard F
    Cancer; 1993 Jun; 71(12):3846-50. PubMed ID: 8508352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Staging of adenocarcinoma of the esophagogastric junction: comparison of AJCC 6th and 7th gastric and 7th esophageal staging systems.
    Kim HI; Cheong JH; Song KJ; An JY; Hyung WJ; Noh SH; Kim CB
    Ann Surg Oncol; 2013 Aug; 20(8):2713-20. PubMed ID: 23456315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is DNA ploidy and proliferative activity of prognostic value in advanced gastric carcinoma?
    Filipe MI; Rosa J; Sandey A; Imrie PR; Ormerod MG; Morris RW
    Hum Pathol; 1991 Apr; 22(4):373-8. PubMed ID: 2050371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of number of metastatic lymph nodes and metastatic lymph node ratio on the prognosis in patients with adenocarcinoma of the esophagogastric junction after curative resection].
    Zhang H; Chen C; Yue J; Ma M; Ma Z; Yu Z
    Zhonghua Zhong Liu Za Zhi; 2014 Feb; 36(2):141-6. PubMed ID: 24796465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome of surgical treatment for early adenocarcinoma of the esophagus or gastro-esophageal junction.
    Westerterp M; Koppert LB; Buskens CJ; Tilanus HW; ten Kate FJ; Bergman JJ; Siersema PD; van Dekken H; van Lanschot JJ
    Virchows Arch; 2005 May; 446(5):497-504. PubMed ID: 15838647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA aneuploidy in gastric carcinoma. Flow cytometric data related to survival, location, and histopathologic findings.
    Flyger HL; Christensen IJ; Thorup J; Håkansson TU; Nørgaard T
    Scand J Gastroenterol; 1995 Mar; 30(3):258-64. PubMed ID: 7770716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA ploidy is stronger than lymph node metastasis as prognostic factor in cervical carcinoma: 10-year results of a prospective study.
    Susini T; Olivieri S; Molino C; Amunni G; Rapi S; Taddei G; Scarselli G
    Int J Gynecol Cancer; 2011 May; 21(4):678-84. PubMed ID: 21412157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nuclear DNA content, tumor cell aggregation, and metastatic events in patients with poorly differentiated adenocarcinoma of the stomach.
    Watanabe A; Korenaga D; Maehara Y; Sugimachi K
    Cancer; 1991 Aug; 68(4):815-20. PubMed ID: 1855182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.